Paper Details

  1. Home
  2. Paper Details

Therapeutic drug monitoring of fenfluramine in clinical practice: Pharmacokinetic variability and impact of concomitant antiseizure medications.

Author: CeulemansBerten, DewalsWendy, PaelinckBernard P, RoosensLaurence, SchoonjansAn-Sofie

Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
Multicenter StudyResearch conducted in collaboration with multiple research institutions. It aims to collect a wide range of data and obtain more generalizable results.
Observational StudyResearch that observes and collects data on participants' behavior and outcomes in their natural state, without intervention.

Overview

This study examined the plasma concentrations and pharmacokinetic variability of fenfluramine (FFA) and its main active metabolite norfenfluramine (norFFA) in patients with refractory epilepsy who were treated with FFA. The study also investigated the interaction of FFA with other antiseizure medications, including stiripentol (STP).
Paper Details　
Original Abstract of the Article :
This study was undertaken to determine the plasma concentration and pharmacokinetic variability of fenfluramine (FFA) and its main active metabolite norfenfluramine (norFFA) in relation to the prevalence of adverse effects in patients with refractory epilepsy treated with FFA. In addition, the inter...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://doi.org/10.1111/epi.17162

データ提供：米国国立医学図書館（NLM）

Therapeutic Drug Monitoring of Fenfluramine in Clinical Practice: Pharmacokinetic Variability and Impact of Concomitant Antiseizure Medications

Imagine our brains as intricate desert cities, with complex pathways for information flow. Epilepsy is like a sandstorm disrupting these pathways, leading to seizures. This research explores the use of fenfluramine (FFA), an antiseizure medication, in treating refractory epilepsy, a type of epilepsy that doesn't respond well to conventional treatments.

Fenfluramine: Managing Variability and Interactions

The study investigated the variability of FFA levels in patients with refractory epilepsy and its interaction with other antiseizure medications. This is like ensuring that the right amount of water is flowing through the desert city's irrigation system to keep the pathways clear and prevent sandstorms. The research highlights the importance of therapeutic drug monitoring to ensure optimal FFA dosage and minimize potential side effects.

Fenfluramine: A Potential Aid in Refractory Epilepsy

For patients with refractory epilepsy, FFA offers a potential solution. This study provides valuable information for healthcare providers to effectively manage FFA therapy and optimize its effectiveness. It's a reminder that even in the unpredictable desert of refractory epilepsy, there might be solutions for calming the sandstorms.

Dr.Camel's Conclusion

This study provides essential information for managing FFA treatment in patients with refractory epilepsy. It's like navigating a complex desert city's irrigation system, ensuring that the right amount of water reaches each part to keep the pathways clear. The research helps us understand how to optimize FFA therapy for maximum benefit and minimum risk. It's a reminder that even in the challenging terrain of refractory epilepsy, there are ways to find solutions and create a more stable environment.
Date :
  1. Date Completed 2022-04-20
  2. Date Revised 2022-04-20
Further Info :

Pubmed ID

35032026

DOI: Digital Object Identifier

10.1111/epi.17162

Related Literature

Article Analysis
・Effects of stiripentol
SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.